We just received data on a new analyst forecast for $THC. Guggenheim gave a rating of 'Buy' for $THC.
$THC Analyst Ratings
Wall Street analysts have issued reports on $THC in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 07/23/2025
- Truist Securities issued a "Buy" rating on 07/16/2025
- Mizuho issued a "Outperform" rating on 07/11/2025
- Morgan Stanley issued a "Overweight" rating on 06/09/2025
- Barclays issued a "Overweight" rating on 06/02/2025
- Wells Fargo issued a "Overweight" rating on 05/29/2025
- B of A Securities issued a "Buy" rating on 05/14/2025
To track analyst ratings and price targets for $THC, check out Quiver Quantitative's $THC forecast page.
$THC Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 12 analysts offer price targets for $THC in the last 6 months, with a median target of $191.5.
Here are some recent targets:
- Jason Cassorla from Guggenheim set a target price of $188.0 on 07/23/2025
- David Macdonald from Truist Securities set a target price of $205.0 on 07/16/2025
- Ann Hynes from Mizuho set a target price of $194.0 on 07/11/2025
- Craig Hettenbach from Morgan Stanley set a target price of $210.0 on 06/09/2025
- Andrew Mok from Barclays set a target price of $215.0 on 06/02/2025
- Stephen Baxter from Wells Fargo set a target price of $195.0 on 05/29/2025
- Kevin Fischbeck from B of A Securities set a target price of $180.0 on 05/14/2025
$THC Insider Trading Activity
$THC insiders have traded $THC stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- JAMES L BIERMAN has made 0 purchases and 4 sales selling 20,000 shares for an estimated $3,249,258.
- PAOLA M ARBOUR (EVP, Chief Information Officer) has made 0 purchases and 2 sales selling 14,199 shares for an estimated $2,373,726.
- J ROBERT KERREY has made 0 purchases and 9 sales selling 15,748 shares for an estimated $2,138,986.
- THOMAS W ARNST (EVP, Chief Admin. Officer & GC) sold 9,786 shares for an estimated $1,624,476
- RICHARD W FISHER has made 0 purchases and 2 sales selling 3,913 shares for an estimated $654,682.
- CECIL D HANEY sold 2,500 shares for an estimated $310,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$THC Hedge Fund Activity
We have seen 288 institutional investors add shares of $THC stock to their portfolio, and 300 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 3,832,530 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $515,475,285
- CITADEL ADVISORS LLC added 1,615,412 shares (+643.2%) to their portfolio in Q1 2025, for an estimated $217,272,914
- AMERIPRISE FINANCIAL INC added 1,524,642 shares (+348.4%) to their portfolio in Q1 2025, for an estimated $205,064,349
- FMR LLC added 1,295,346 shares (+17.9%) to their portfolio in Q1 2025, for an estimated $174,224,037
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,165,529 shares (-82.7%) from their portfolio in Q1 2025, for an estimated $156,763,650
- BLACKROCK, INC. removed 1,056,210 shares (-10.0%) from their portfolio in Q1 2025, for an estimated $142,060,245
- BOSTON PARTNERS added 1,016,010 shares (+692.9%) to their portfolio in Q1 2025, for an estimated $136,653,345
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
.jpg)